Lineage Cell Therapeutics (LCTX) Notes Payables (2015 - 2019)
Lineage Cell Therapeutics posted quarterly Notes Payables of $18000.0 for Q1 2019, down 85.0% year-on-year from $120000.0 in Q1 2018, and down 74.29% on a QoQ basis from $70000.0 in Q4 2018.
Lineage Cell Therapeutics (LCTX) has 5 years of Notes Payables data on file, last reported at $18000.0 in Q1 2019.
- For the quarter ending Q1 2019, Notes Payables fell 85.0% year-over-year to $18000.0; the trailing twelve-month figure through Mar 2019 stood at $18000.0 (down 85.0% YoY), and the FY2018 full-year result was $70000.0, down 53.95% from the prior year.
- Notes Payables for Q1 2019 stood at $18000.0, down from $70000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $2.6 million in Q2 2017 and bottomed at $13000.0 in Q3 2017.
- The 5-year median for Notes Payables is $95000.0 (2015), against an average of $253375.0.
- The widest annual swing landed in 2017, when Notes Payables jumped 2589.47%; it then tumbled 95.3% in 2018.
- A 5-year view of Notes Payables shows it stood at $95000.0 in 2015, then advanced by 4.21% to $99000.0 in 2016, then jumped by 53.54% to $152000.0 in 2017, then sank by 53.95% to $70000.0 in 2018, then plunged by 74.29% to $18000.0 in 2019.
- The last three Notes Payables figures came in at $18000.0 (Q1 2019), $70000.0 (Q4 2018), and $70000.0 (Q3 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lineage Cell Therapeutics | 325.89 Mn | 261.99 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 18,000.00 |
| Dec 31, 2018 | 70,000.00 |
| Sep 30, 2018 | 70,000.00 |
| Jun 30, 2018 | 120,000.00 |
| Mar 31, 2018 | 120,000.00 |
| Dec 31, 2017 | 152,000.00 |
| Sep 30, 2017 | 13,000.00 |
| Jun 30, 2017 | 2.56 Mn |
| Mar 31, 2017 | 124,000.00 |
| Dec 31, 2016 | 99,000.00 |
| Sep 30, 2016 | 95,000.00 |
| Jun 30, 2016 | 95,000.00 |
| Mar 31, 2016 | 95,000.00 |
| Dec 31, 2015 | 95,000.00 |
| Sep 30, 2015 | 95,000.00 |
| Jun 30, 2015 | 238,000.00 |